
The January Barometer, a well-known indicator of market performance for
the calendar year, suggests that 2008 will be a disappointing year for
investors in the U.S. stock market. Before you sell off all
your investments, lets look at why this year may be different.
Developed by Yale Hirsch of The Stock Market Almanac in 1972, this
popular market indicator states that “as the S&P goes in January, so
goes the year.”
Simply put, if the S&P 500 finishes January with a
positive return, it is highly likely that the index will finish the year
with a positive return as well. Conversely, a negative return in January
foreshadows a market decline for the year.
The Almanac further claims this indicator has accurately predicted
market performance for the year 91.2% of the time since 1950. A
remarkable track record by any measure.
So what does this mean for investors in 2008?
On the heels of an anemic gain of just 3.5% in 2007, the S&P 500 posted
a loss of 1.4% on the first day of trading in 2008. The index continued
its decline largely unimpeded through the end of the month due to a
number of reasons which we're all aware of by now.
Although the market recovered from the steep intra-day lows set on
January 22nd and 23rd thanks to the Fed’s emergency rate cut, the S&P
500 finished January at 1,378 for a loss of 6.1%.
Now, before you panic and go short, know that there are several interesting
factors at play this year that could portend a gain for U.S.
stocks in 2008 and prove the Almanac wrong this year.
-------------Sponsor-------------
Where Can You Turn $300 Into $1.3 Million Right Now?
Our own small-company specialist, Robert Morris, has found a
way to 'sniff out' tiny penny stocks on the verge of a major breakout. And
the timing for this has never been better.
You see, the system takes advantage of an obscure SEC regulation that
sends penny stock prices through the roof.
We've seen some stocks gain 852%... 5,450%... even 17,496% in no time
flat.
Click here
for the details...
-----------------------------------

| Company | Gain | |
| Middlebrook Pharma (MBRK) | 159% | |
| EDO Corp. (EDO) | 136% | |
| Raser Technologies (RZ) | 122% | |
| Challenger Energy (CHQ) | 101% | |
| Ardea Biosciences (ARDC) | 98% | |
| Company | Loss | |
| MoneyGram (MGI) | 65% | |
| ShoreTel (SHOR) | 64% | |
| Cadence Pharma (CADX) | 62% | |
| SUNOPTA (STKL) | 59% | |
| Twin Disc (TWIN) | 57% | |